Quick Answer
IMMUCELL CORP /DE/ reported Total Assets of $42.53 million for the year ending 2025.
- IMMUCELL CORP /DE/ showed a decrease of -5.7% in Total Assets from 2024 to 2025.
- This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $11.29 million | Q3 2011: $10.98 million | Q1 2012: $11.17 million | Q3 2012: $10.97 million | Q1 2013: $11.11 million | Q2 2013: $11.37 million | Q3 2013: $11.07 million | Q1 2014: $11.12 million | Q2 2014: $10.77 million | Q3 2014: $10.74 million | Q1 2015: $11.23 million | Q2 2015: $11.24 million | Q3 2015: $14.22 million | Q1 2016: $20.38 million | Q2 2016: $20.57 million | Q3 2016: $20.58 million | Q1 2017: $25.33 million | Q2 2017: $28.06 million | Q3 2017: $30.29 million | Q2 2018: $32.74 million | Q3 2018: $33.24 million | Q1 2019: $40.48 million | Q2 2019: $39.41 million | Q3 2019: $38.85 million | Q1 2020: $40.05 million | Q2 2020: $40.66 million | Q3 2020: $39.99 million | Q1 2021: $39.62 million | Q2 2021: $43.73 million | Q3 2021: $44.23 million | Q4 2021: $44.47 million | Q1 2022: $46.70 million | Q2 2022: $45.98 million | Q3 2022: $46.40 million | Q4 2022: $44.86 million | Q1 2023: $43.12 million | Q2 2023: $44.01 million | Q3 2023: $44.55 million | Q4 2023: $43.81 million | Q1 2024: $43.05 million | Q2 2024: $41.86 million | Q3 2024: $44.45 million | Q1 2025: $45.62 million | Q2 2025: $46.72 million | Q3 2025: $45.73 million.
- Over the full 16 years of available data (2010 to 2025), IMMUCELL CORP /DE/'s Total Assets has grown by 295.6%.
- Historical annual values: Fiscal year 2025: $42.53 million | Fiscal year 2024: $45.10 million | Fiscal year 2023: $43.81 million | Fiscal year 2022: $44.86 million | Fiscal year 2021: $44.47 million | Fiscal year 2020: $40.35 million | Fiscal year 2019: $38.69 million | Fiscal year 2018: $32.73 million | Fiscal year 2017: $34.30 million | Fiscal year 2016: $24.70 million | Fiscal year 2015: $14.54 million | Fiscal year 2014: $11.05 million | Fiscal year 2013: $10.96 million | Fiscal year 2012: $11.03 million | Fiscal year 2011: $10.99 million | Fiscal year 2010: $10.75 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: